FDA Drug Application (021055) for TARGRETIN by VALEANT LUXEMBOURG

Back to FDA Applications sponsored by VALEANT LUXEMBOURG

Application Number021055
Product Number001
FormCAPSULE;ORAL
Dosage75MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTARGRETIN
Active IngredientBEXAROTENE



Back to FDA Applications sponsored by VALEANT LUXEMBOURG

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.